Mathieu Perez
MD-PhD Candidate
He is deeply interested in understanding neuro-vulnerability in neurodegeneration. In the labs of Omer Bayraktar and Andrew Bassett at the Sanger Institute, and Michael Ward at NINDS-NIH, he works with cutting-edge omics modalities and imaging techniques to identify neuronal subpopulations vulnerable to neurodegenerative disorders. A central focus of his approach is the development of high-throughput optical pooled screens for thorough neuronal characterization. His primary goal is to use these innovative tools to uncover disease-specific neuronal vulnerabilities. This research is driven by a broader vision to apply these methodologies across a range of neurodegenerative diseases, ultimately aiming to make a significant contribution to the understanding and potential treatment of these complex disorders
As an MD-PhD trainee in the MSTP track at UCSF and Cambridge, he is committed to translating and advancing medicine through the use of large-scale data, high-throughput imaging modalities, and biophysical measurements . His focus is particularly on unveiling fundamental biological insights for the development of novel diagnostics, therapeutics, and treatments.